Cannabinoid Receptor

大麻素受体 (Cannabinoid Receptor) 目前分为三类:中枢(CB1)、外周(CB2)和 GPR55,它们都是 G 蛋白偶联的。CB1 受体主要位于中枢和外周神经末梢。CB2 受体主要在非神经元组织中表达,特别是免疫细胞,它们在那里调节细胞因子的释放和细胞迁移。最近的报告表明,CB2 受体也可能在中枢神经系统中表达。GPR55 受体是非 CB1/CB2 受体,对内源性、植物性和合成大麻素具有亲和性。已发现大麻素受体的内源性配体,包括花生四烯酸乙醇胺和 2-花生四烯酸甘油酯。

Cannabinoid receptors are currently classified into three groups: central (CB1), peripheral (CB2) and GPR55, all of which are G-protein-coupled. CB1 receptors are primarily located at central and peripheral nerve terminals. CB2 receptors are predominantly expressed in non-neuronal tissues, particularly immune cells, where they modulate cytokine release and cell migration. Recent reports have suggested that CB2 receptors may also be expressed in the CNS. GPR55 receptors are non-CB1/CB2 receptors that exhibit affinity for endogenous, plant and synthetic cannabinoids. Endogenous ligands for cannabinoid receptors have been discovered, including anandamide and 2-arachidonylglycerol.

Cannabinoid Receptor亚型特异性产品:Cannabinoid Receptor Isoform Comparison
共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
PROTAC CB1R Degrader-1

PROTAC CB1R Degrader-1 是一种强效且选择性的 CB1R PROTAC 降解剂,通过泛素-蛋白酶体系统 (UPS) 介导 CB1R 降解,在 MCF-7 细胞中的 DC50 为 3.37 μM,且对 CB2R 无影响,可降低 CB1R 相关下游信号通路 (p-AKT、p-ERK、BCL2 和 MCM5),从而抑制乳腺癌细胞增殖并诱导细胞凋亡 (apoptosis),可用于乳腺癌相关研究(粉色:CB1R 配体 (MS-G91895);蓝色:Cereblon 配体 (MS-V29738);黑色:连接子 (MS-J53679))。

Degrader
PROTAC CB1R Degrader-1

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础